Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2013091704) PHARMACEUTICAL COMPOSITION COMPRISING FINGOLIMOD
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2013/091704 International Application No.: PCT/EP2011/073758
Publication Date: 27.06.2013 International Filing Date: 22.12.2011
IPC:
A61K 9/48 (2006.01) ,A61K 31/137 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
Applicants:
SYNTHON BV [NL/NL]; Microweg 22 NL-6545 CM Nijmegen, NL (AllExceptUS)
ASCASO ANGLÉS, Magda [ES/ES]; ES (UsOnly)
ÁLVAREZ FERNÁNDEZ, Lisardo [ES/ES]; ES (UsOnly)
Inventors:
ASCASO ANGLÉS, Magda; ES
ÁLVAREZ FERNÁNDEZ, Lisardo; ES
Priority Data:
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING FINGOLIMOD
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT LE FINGOLIMOD
Abstract:
(EN) The present invention relates to a pharmaceutical composition suitable for oral administration of Fingolimod, which composition exhibits improved stability and has advantageous properties in making orally administrable final dosage forms such as capsules or tablets. The composition comprises Fingolimod and-or a pharmaceutically acceptable salt or ester thereof, calcium lactate pentahydrate and, optionally, a lubricant.
(FR) La présente invention concerne une composition pharmaceutique appropriée pour une administration par voie orale du Fingolimod, ladite composition présentant une stabilité améliorée et des propriétés avantageuses dans la fabrication de formes galéniques finales pouvant être administrées par voie orale telles que les capsules ou les comprimés. La composition selon l'invention comprend le Fingolimod et/ou un sel ou un ester pharmaceutiquement acceptable de celui-ci, du lactate de calcium pentahydraté et, éventuellement, un lubrifiant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)